Bot Image is expanding its ProstatID MR system compatibility. We are seeking #radiologists for beta testing and a clinical study. Email [email protected] for more information.
Sorry we missed everyone in person at #RSNA21, it looks like a great time! You can still see us at our virtual booth until we're back next year.
https://t.co/0h37mXYqNo
Bot Image is expanding its ProstatID MR system compatibility. We are seeking #radiologists for beta testing and a clinical study. Email [email protected] for more information.
We recently sat down with our Founder to have a quick conversation about what motivated him to start Bot Image and the potential impact of ProstatID.
Check it out: https://t.co/kknG1pweT3
FocalNet, a new artificial intelligence (#AI) system developed by #UCLA researchers, improves radiologists’ ability to diagnose #prostatecancer. ➨ https://t.co/0eWB28jAns
.@botimageai is an #AI#software tool for accurately identifying cancer based on MRI images. @botimageai's ProstatID helps patients identify whether they have prostate cancer (the 2nd leading cause of cancer death for men). #Omaha#startup#medtech https://t.co/ZHrej58Lfb
Getting excited for #AHRA2019 in Denver! Stop by our booth 1618 to learn more about how our diagnostic #ArtificialIntelligence software can help your prostate cancer patients.